Literature DB >> 10797614

Temporal analysis of growth factor mRNA expression in myelinating rat brain aggregate cultures: increments in CNTF, FGF-2, IGF-I, and PDGF-AA mRNA are induced by antibody-mediated demyelination.

C A Copelman1, M L Cuzner, N Groome, L T Diemel.   

Abstract

Myelinogenesis in rat brain aggregate cultures is associated with a pattern of growth factor mRNA expression comparable to that of the developing brain. The rate of increase in platelet-derived growth factor-AA (PDGF-AA) expression was greatest just before the detection of myelin basic protein (MBP) mRNA in the cultures and remained high thereafter, consistent with in vivo observations. Levels of fibroblast growth factor-2 (FGF-2) and of ciliary neurotrophic factor (CNTF) mRNA increased continuously over the period of MBP accumulation. High rates of transforming growth factor beta1 (TGF-beta1), insulin-like growth factor-I (IGF-I), and neurotrophin-3 (NT-3) expression at early time points during the culture gradually decreased over time, indicative of a key regulatory role during oligodendrocyte development. The addition of demyelinative anti-myelin oligodendrocyte glycoprotein (anti-MOG) antibody resulted in a significant increase in MBP peptide fragments with a C-terminus at phenylalanine 89 indicating proteolytic breakdown of MBP after myelin phagocytosis. Immediately after antibody treatment the expression of CNTF mRNA was significantly increased, compared with controls, while that of FGF-2 and IGF-I, and of PDGF-AA peaked during the early and later stages of recovery respectively. Thus, specific growth factors combine to regulate myelination and remyelination in the aggregates; these data have implications for demyelinating disease in which protective growth factor secretion may be central to regeneration. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797614     DOI: 10.1002/(sici)1098-1136(200006)30:4<342::aid-glia30>3.0.co;2-8

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  11 in total

Review 1.  Stem cell therapy for central nervous system demyelinating disease.

Authors:  Louis N Manganas; Mirjana Maletic-Savatic
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

2.  Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.

Authors:  Miki Furusho; Aude J Roulois; Robin J M Franklin; Rashmi Bansal
Journal:  Glia       Date:  2015-04-22       Impact factor: 7.452

3.  A versatile 3D culture model facilitates monitoring of astrocytes undergoing reactive gliosis.

Authors:  Emma East; Jonathan P Golding; James B Phillips
Journal:  J Tissue Eng Regen Med       Date:  2009-12       Impact factor: 3.963

4.  Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity.

Authors:  Deanna L Taylor; Lara T Diemel; Jennifer M Pocock
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

5.  Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming.

Authors:  Viktoria Gudi; Jelena Škuljec; Özlem Yildiz; Konstantin Frichert; Thomas Skripuletz; Darius Moharregh-Khiabani; Elke Voss; Kirsten Wissel; Sabine Wolter; Martin Stangel
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

6.  Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury.

Authors:  Soya Kawabata; Morito Takano; Yuko Numasawa-Kuroiwa; Go Itakura; Yoshiomi Kobayashi; Yuichiro Nishiyama; Keiko Sugai; Soraya Nishimura; Hiroki Iwai; Miho Isoda; Shinsuke Shibata; Jun Kohyama; Akio Iwanami; Yoshiaki Toyama; Morio Matsumoto; Masaya Nakamura; Hideyuki Okano
Journal:  Stem Cell Reports       Date:  2015-12-24       Impact factor: 7.765

Review 7.  In vitro and in vivo pharmacological models to assess demyelination and remyelination.

Authors:  Jean E Merrill
Journal:  Neuropsychopharmacology       Date:  2008-09-17       Impact factor: 7.853

Review 8.  What roles do growth factors play in CNS remyelination?

Authors:  R J Franklin; G L Hinks; R H Woodruff; M T O'Leary
Journal:  Prog Brain Res       Date:  2001       Impact factor: 2.453

9.  Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins.

Authors:  Robert P Lisak; Joyce A Benjamins; Beverly Bealmear; Liljana Nedelkoska; Bin Yao; Susan Land; Diane Studzinski
Journal:  J Neuroinflammation       Date:  2007-12-18       Impact factor: 8.322

Review 10.  Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.

Authors:  Viktoria Gudi; Stefan Gingele; Thomas Skripuletz; Martin Stangel
Journal:  Front Cell Neurosci       Date:  2014-03-13       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.